Cellectis SA (CLLS)
2.91
-0.04
(-1.36%)
USD |
NASDAQ |
May 22, 16:00
2.91
0.00 (0.00%)
After-Hours: 16:28
Cellectis Cash from Operations (Quarterly): 39.72M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.72M |
| September 30, 2023 | -17.09M |
| June 30, 2023 | -19.04M |
| March 31, 2023 | -28.33M |
| December 31, 2022 | -1.22M |
| September 30, 2022 | -26.04M |
| June 30, 2022 | -23.57M |
| March 31, 2022 | -36.61M |
| December 31, 2021 | -21.08M |
| September 30, 2021 | -30.43M |
| June 30, 2021 | -12.12M |
| March 31, 2021 | -40.93M |
| December 31, 2020 | -33.89M |
| September 30, 2020 | -25.61M |
| June 30, 2020 | -22.22M |
| March 31, 2020 | 1.458M |
| December 31, 2019 | -2.882M |
| September 30, 2019 | -22.65M |
| Date | Value |
|---|---|
| June 30, 2019 | -21.22M |
| March 31, 2019 | -22.40M |
| December 31, 2018 | -20.60M |
| September 30, 2018 | -15.01M |
| June 30, 2018 | -12.54M |
| March 31, 2018 | -19.98M |
| December 31, 2017 | -9.513M |
| September 30, 2017 | -15.49M |
| June 30, 2017 | -11.04M |
| March 31, 2017 | -16.28M |
| December 31, 2016 | 1.664M |
| September 30, 2016 | -2.007M |
| June 30, 2016 | -10.16M |
| March 31, 2016 | -22.20M |
| December 31, 2015 | 28.33M |
| September 30, 2015 | -5.235M |
| June 30, 2015 | -18.18M |
| March 31, 2015 | -1.320M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-40.93M
Minimum
Mar 2021
39.72M
Maximum
Dec 2023
-18.09M
Average
-22.22M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| DBV Technologies SA | -34.69M |
| Biophytis SA | -- |
| Genfit SA | -- |
| Edap TMS SA | -4.073M |
| Adaptimmune Therapeutics PLC | -31.95M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -13.65M |
| Cash from Financing (Quarterly) | 41.58M |
| Free Cash Flow | -25.82M |
| Free Cash Flow Per Share (Quarterly) | 0.6035 |
| Free Cash Flow to Equity (Quarterly) | 37.77M |
| Free Cash Flow to Firm (Quarterly) | 61.34M |
| Free Cash Flow Yield | -15.54% |